Sign in

CIK 0001719406

  • Non-accelerated filer
  • Smaller reporting company

NRX Pharmaceuticals, Inc.

Sign in to watch
Ticker
NRXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
822844431
Phone
+1 484-254-6134
Business address
1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
Former names
Big Rock Partners Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-04-09 Hurvitz Chaim Director Grant or award · Stock Option (right to buy) +25,000 25,000
2023-08-30 Hurvitz Chaim Director Purchase +70,000 $0.29 $20K 570,000
2022-11-18 Hurvitz Chaim Director Purchase +40,408 $1.10 $44K 500,000
2022-11-18 Hurvitz Chaim Director Purchase +40,408 $1.10 $44K 500,000
2022-11-17 Hurvitz Chaim Director Purchase +171,780 $1.08 $186K 459,592
2022-11-17 Hurvitz Chaim Director Purchase +171,780 $1.08 $186K 459,592
2022-11-16 Hurvitz Chaim Director Purchase +287,812 $0.99 $285K 287,812
2022-11-16 Hurvitz Chaim Director Purchase +287,812 $0.99 $285K 287,812
2022-10-21 Hurvitz Chaim Director Grant or award · Employee Stock Option +162,660 381,083
2021-05-24 Hurvitz Chaim Director Grant or award +1,436,350 1,436,350
2021-05-24 Hurvitz Chaim Director Grant or award +208,443 208,443
2021-05-24 Hurvitz Chaim Director Grant or award · Common Stock Warrant (Right to buy) +218,423 218,423

Page 1 of 1 · 12 trades